UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 168

Sortiert nach

Primed CD8+ T‐Cell Responses to Allogeneic Endothelial Cells Are Controlled by Local Complement Activation

American journal of transplantation, 2009-08, Vol.9 (8), p.1784-1795

2009

Link zum Volltext

Verfügbarkeit prüfen

Decay Accelerating Factor is Essential for Successful Corneal Engraftment

American journal of transplantation, 2010-03, Vol.10 (3), p.527-534

2010

Link zum Volltext

Verfügbarkeit prüfen

Differential cytokine expression of human retinal pigment epithelial cells in response to stimulation by C5a

Clinical and experimental immunology, 2003-02, Vol.131 (2), p.248-253

2003

Link zum Volltext

Verfügbarkeit prüfen

Structure/function studies of human decay‐accelerating factor

Immunology, 2000-09, Vol.101 (1), p.104-111

2000

Link zum Volltext

Verfügbarkeit prüfen

Cooperation Between Decay-Accelerating Factor and Membrane Cofactor Protein in Protecting Cells from Autologous Complement Attack

The Journal of immunology (1950), 2000-10, Vol.165 (7), p.3999-4006

2000

Link zum Volltext

Verfügbarkeit prüfen

A Knock-Out Model of Paroxysmal Nocturnal Hemoglobinuria: Pig-a- Hematopoiesis is Reconstituted Following Intercellular Transfer of GPI-Anchored Proteins

Proceedings of the National Academy of Sciences - PNAS, 1996-07, Vol.93 (15), p.7938-7943

1996

Link zum Volltext

Verfügbarkeit prüfen

Characterization of the Active Sites in Decay-Accelerating Factor

The Journal of immunology (1950), 2001-08, Vol.167 (4), p.2164-2171

2001

Link zum Volltext

Verfügbarkeit prüfen

Characterization of putative glycoinositol phospholipid anchor precursors in mammalian cells. Localization of phosphoethanolamine

The Journal of biological chemistry, 1992-08, Vol.267 (24), p.16968-16974

1992

Link zum Volltext

Verfügbarkeit prüfen

Tears contain the complement regulator CD59 as well as decay‐accelerating factor (DAF)

Clinical and experimental immunology, 2001-02, Vol.123 (2), p.188-195

2001

Link zum Volltext

Verfügbarkeit prüfen

Localization of classical and alternative pathway regulatory activity within the decay-accelerating factor

The Journal of immunology (1950), 1996-04, Vol.156 (7), p.2528

1996

Link zum Volltext

Verfügbarkeit prüfen

Identification of the complement decay-accelerating factor (DAF) on epithelium and glandular cells and in body fluids

The Journal of experimental medicine, 1987-03, Vol.165 (3), p.848-864

1987

Link zum Volltext

Verfügbarkeit prüfen

Cloning and Characterization of cDNAs Encoding the Complete Sequence of Decay-Accelerating Factor of Human Complement

Proceedings of the National Academy of Sciences - PNAS, 1987-04, Vol.84 (7), p.2007-2011

1987

Link zum Volltext

Verfügbarkeit prüfen

Deficient biosynthesis of N-acetylglucosaminyl-phosphatidylinositol, the first intermediate of glycosyl phosphatidylinositol anchor biosynthesis, in cell lines established from patients with paroxysmal nocturnal hemoglobinuria

The Journal of experimental medicine, 1993-02, Vol.177 (2), p.517-521

1993

Link zum Volltext

Verfügbarkeit prüfen

Genetic Defects Underlying Paroxysmal Nocturnal Hemoglobinuria That Arises Out of Aplastic Anemia

Blood, 1995-12, Vol.86 (12), p.4656-4661

1995

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes

The Journal of experimental medicine, 1984-11, Vol.160 (5), p.1558-1578

1984

Link zum Volltext

Verfügbarkeit prüfen

Structural basis for variations in the sensitivity of human decay accelerating factor to phosphatidylinositol-specific phospholipase C cleavage

The Journal of immunology (1950), 1990-02, Vol.144 (3), p.1030

1990

Link zum Volltext

Verfügbarkeit prüfen

Antigen-presenting cell engineering : the molecular toolbox

The American journal of pathology, 1996, Vol.148 (1), p.1-16

1996

Link zum Volltext

Verfügbarkeit prüfen

Distribution of decay-accelerating factor in the peripheral blood of normal individuals and patients with paroxysmal nocturnal hemoglobinuria

The Journal of experimental medicine, 1985-07, Vol.162 (1), p.75-92

1985

Link zum Volltext

Verfügbarkeit prüfen

Assembly and Deacetylation of N-Acetylglucosaminyl-Plasmanylinositol in Normal and Affected Paroxysmal Nocturnal Hemoglobinuria Cells

Proceedings of the National Academy of Sciences - PNAS, 1991-05, Vol.88 (9), p.3762-3766

1991

Link zum Volltext

Verfügbarkeit prüfen

Affected paroxysmal nocturnal hemoglobinuria T lymphocytes harbor a common defect in assembly of N-acetyl-D-glucosamine inositol phospholipid corresponding to that in class A Thy-1- murine lymphoma mutants

The Journal of biological chemistry, 1992-12, Vol.267 (35), p.25347-25351

1992

Link zum Volltext

Verfügbarkeit prüfen

Lipid Protein Interactions: The Assembly of CD1d1 with Cellular Phospholipids Occurs in the Endoplasmic Reticulum

The Journal of immunology (1950), 2002-01, Vol.168 (2), p.723-733

2002

Link zum Volltext

Verfügbarkeit prüfen

Expression of the DAF (CD55) and CD59 antigens during normal hematopoietic cell differentiation

Journal of leukocyte biology, 1992-12, Vol.52 (6), p.652-660

1992

Link zum Volltext

Verfügbarkeit prüfen

Activation of the alternative complement pathway by exposure of phosphatidylethanolamine and phosphatidylserine on erythrocytes from sickle cell disease patients

The Journal of clinical investigation, 1993-09, Vol.92 (3), p.1326-1335

1993

Link zum Volltext

Verfügbarkeit prüfen

Glycoinositol phospholipid anchor-defective K562 mutants with biochemical lesions distinct from those in Thy-1- murine lymphoma mutants

The Journal of biological chemistry, 1994-03, Vol.269 (9), p.6536-6542

1994

Link zum Volltext

Verfügbarkeit prüfen

Tissue distribution of products of the mouse decay‐accelerating factor (DAF) genes. Exploitation of a Daf1 knock‐out mouse and site‐specific monoclonal antibodies

Immunology, 2001-10, Vol.104 (2), p.215-225

2001

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 168

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(161)
Mit Volltextzugriff
(136)

Publikationsform

Artikel
(167)
Bücher
(1)

Sprache

Englisch
(168)
Japanisch
(26)

Erscheinungsjahr

n.n

Thema

Science & Technology
(127)
Humans
(125)
Life Sciences & Biomedicine
(110)
Biological And Medical Sciences
(65)
Animals
(55)
Immunology
(43)
Fundamental And Applied Biological Sciences. Psychology
(39)
Cd55 Antigens
(34)
Mice
(31)
Complement
(29)
Biochemistry & Molecular Biology
(28)
Medical Sciences
(27)
Molecular Sequence Data
(26)
Cell Line
(25)
Female
(21)
Glycosylphosphatidylinositols - Metabolism
(21)
Hela Cells
(20)
Medicine, Research & Experimental
(20)
Research & Experimental Medicine
(20)
Cd55 Antigens - Metabolism
(19)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Primed CD8+ T‐Cell Responses to Allogeneic Endothelial Cells Are Controlled by Local Complement Activation

Decay Accelerating Factor is Essential for Successful Corneal Engraftment

Differential cytokine expression of human retinal pigment epithelial cells in response to stimulation by C5a

Structure/function studies of human decay‐accelerating factor

Cooperation Between Decay-Accelerating Factor and Membrane Cofactor Protein in Protecting Cells from Autologous Complement Attack

A Knock-Out Model of Paroxysmal Nocturnal Hemoglobinuria: Pig-a- Hematopoiesis is Reconstituted Following Intercellular Transfer of GPI-Anchored Proteins

Characterization of the Active Sites in Decay-Accelerating Factor

Characterization of putative glycoinositol phospholipid anchor precursors in mammalian cells. Localization of phosphoethanolamine

Tears contain the complement regulator CD59 as well as decay‐accelerating factor (DAF)

Localization of classical and alternative pathway regulatory activity within the decay-accelerating factor

Identification of the complement decay-accelerating factor (DAF) on epithelium and glandular cells and in body fluids

Cloning and Characterization of cDNAs Encoding the Complete Sequence of Decay-Accelerating Factor of Human Complement

Deficient biosynthesis of N-acetylglucosaminyl-phosphatidylinositol, the first intermediate of glycosyl phosphatidylinositol anchor biosynthesis, in cell lines established from patients with paroxysmal nocturnal hemoglobinuria

Genetic Defects Underlying Paroxysmal Nocturnal Hemoglobinuria That Arises Out of Aplastic Anemia

Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes

Structural basis for variations in the sensitivity of human decay accelerating factor to phosphatidylinositol-specific phospholipase C cleavage

Antigen-presenting cell engineering : the molecular toolbox

Distribution of decay-accelerating factor in the peripheral blood of normal individuals and patients with paroxysmal nocturnal hemoglobinuria

Assembly and Deacetylation of N-Acetylglucosaminyl-Plasmanylinositol in Normal and Affected Paroxysmal Nocturnal Hemoglobinuria Cells

Affected paroxysmal nocturnal hemoglobinuria T lymphocytes harbor a common defect in assembly of N-acetyl-D-glucosamine inositol phospholipid corresponding to that in class A Thy-1- murine lymphoma mutants

Lipid Protein Interactions: The Assembly of CD1d1 with Cellular Phospholipids Occurs in the Endoplasmic Reticulum

Expression of the DAF (CD55) and CD59 antigens during normal hematopoietic cell differentiation

Activation of the alternative complement pathway by exposure of phosphatidylethanolamine and phosphatidylserine on erythrocytes from sickle cell disease patients

Glycoinositol phospholipid anchor-defective K562 mutants with biochemical lesions distinct from those in Thy-1- murine lymphoma mutants

Tissue distribution of products of the mouse decay‐accelerating factor (DAF) genes. Exploitation of a Daf1 knock‐out mouse and site‐specific monoclonal antibodies

Suchergebnisse filtern